Last Updated: Wednesday, October 2, 2013, 13:34
Emphasising that pricing aspects of pharmaceuticals are critical for the general public, CCI Chairman Ashok Chawla has said that some cases of probe into alleged unfair practices in this space are in the "pipeline".